<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00382903819119</udiDi>
    <basicUdiDi>038290FYLKFOEMEG</basicUdiDi>
    <tradeName>INSYTE-N AUTOGUARD</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>381911</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T19:43:11.576Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903916603</udiDi>
    <basicUdiDi>038290GHXYEBLCDH</basicUdiDi>
    <tradeName>NEOFLON</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>391660</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T19:43:11.252Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903812110</udiDi>
    <basicUdiDi>038290FVWUNBPFM4</basicUdiDi>
    <tradeName>INSYTE-N</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>381211</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T19:43:11.218Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903829125</udiDi>
    <basicUdiDi>038290OAODRZZNC9</basicUdiDi>
    <tradeName>Insyte AUTOGUARD</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>382912</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T19:43:11.204Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903818129</udiDi>
    <basicUdiDi>038290TFYRGYXIPP</basicUdiDi>
    <tradeName>Insyte AUTOGUARD</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>381812</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T19:42:52.881Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903819126</udiDi>
    <basicUdiDi>038290HDSBCRGE3R</basicUdiDi>
    <tradeName>Insyte AUTOGUARD</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>381912</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T19:42:43.012Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903810123</udiDi>
    <basicUdiDi>038290HDCOZIJX6T</basicUdiDi>
    <tradeName>Insyte AUTOGUARD</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>381012</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T19:41:50.180Z</lastUpdated>
  </row>
  <row>
    <udiDi>00382903818112</udiDi>
    <basicUdiDi>038290KCPPHCMV8Y</basicUdiDi>
    <tradeName>INSYTE-N AUTOGUARD</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>381811</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T19:41:36.525Z</lastUpdated>
  </row>
  <row>
    <udiDi>30382903913894</udiDi>
    <basicUdiDi>038290ZCNOSRXLMV</basicUdiDi>
    <tradeName>NEOFLON</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>391389</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T02:17:14.455Z</lastUpdated>
  </row>
  <row>
    <udiDi>30382903913900</udiDi>
    <basicUdiDi>038290ZCNOSRXLMV</basicUdiDi>
    <tradeName>NEOFLON</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>391390</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T02:17:14.436Z</lastUpdated>
  </row>
  <row>
    <udiDi>30382903932321</udiDi>
    <basicUdiDi>038290CPXPNDXWGX</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393232</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T02:17:14.417Z</lastUpdated>
  </row>
  <row>
    <udiDi>30382903932345</udiDi>
    <basicUdiDi>038290CPXPNDXWGX</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393234</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T02:17:14.400Z</lastUpdated>
  </row>
  <row>
    <udiDi>30382903932369</udiDi>
    <basicUdiDi>038290CPXPNDXWGX</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393236</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T02:17:14.387Z</lastUpdated>
  </row>
  <row>
    <udiDi>30382903932376</udiDi>
    <basicUdiDi>038290CPXPNDXWGX</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393237</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T02:17:14.371Z</lastUpdated>
  </row>
  <row>
    <udiDi>30382903932383</udiDi>
    <basicUdiDi>038290CPXPNDXWGX</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393238</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T02:17:14.348Z</lastUpdated>
  </row>
  <row>
    <udiDi>30382903932390</udiDi>
    <basicUdiDi>038290CPXPNDXWGX</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393239</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T02:17:14.326Z</lastUpdated>
  </row>
  <row>
    <udiDi>30382903932406</udiDi>
    <basicUdiDi>038290CPXPNDXWGX</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393240</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T02:17:14.304Z</lastUpdated>
  </row>
  <row>
    <udiDi>30382903932437</udiDi>
    <basicUdiDi>038290CRHGWSVQC6</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393243</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T02:17:14.285Z</lastUpdated>
  </row>
  <row>
    <udiDi>30382903932451</udiDi>
    <basicUdiDi>038290CRHGWSVQC6</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393245</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T02:17:14.261Z</lastUpdated>
  </row>
  <row>
    <udiDi>30382903932598</udiDi>
    <basicUdiDi>038290CRHGWSVQC6</basicUdiDi>
    <tradeName>Venflon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Becton Dickinson Infusion Therapy Systems Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000017719</manufacturerSrn>
    <authorisedRepresentativeName>Becton Dickinson Ireland Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000007610</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>393259</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T02:17:14.238Z</lastUpdated>
  </row>
</eudamedExport>